PMV Pharmaceuticals, Inc. short interest in 2022
In 2022, PMV Pharmaceuticals, Inc.'s disclosed short interest ran from 10.63% of shares outstanding on 14 Jan 2022 to 20.78% on 30 Dec 2022, a change of +10.15 percentage points. The year's high was 31.56% on 15 Jul 2022 and its low 10.63% on 14 Jan 2022, averaging 22.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.64 days on 14 Oct 2022. Full history: PMV Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 10.63% (14 Jan 2022)
- End of year
- 20.78% (30 Dec 2022)
- Change
- +10.15 pp
- High
- 31.56% (15 Jul 2022)
- Low
- 10.63% (14 Jan 2022)
- Average
- 22.93%
- Highest days to cover
- 26.64 (14 Oct 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 10.63% | 5.55 | |
| 31 Jan 2022 | 12.10% | 9.86 | |
| 15 Feb 2022 | 15.27% | 6.99 | |
| 28 Feb 2022 | 16.92% | 9.10 | |
| 15 Mar 2022 | 18.16% | 15.69 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 17.57% | 9.33 | |
| 14 Apr 2022 | 17.11% | 8.67 | |
| 29 Apr 2022 | 21.09% | 8.46 | |
| 13 May 2022 | 25.34% | 10.45 | 10-Q filed, results (8-K) |
| 31 May 2022 | 26.98% | 5.31 | |
| 15 Jun 2022 | 26.65% | 4.68 | |
| 30 Jun 2022 | 30.05% | 6.20 | |
| 15 Jul 2022 | 31.56% | 17.25 | |
| 29 Jul 2022 | 30.21% | 24.12 | |
| 15 Aug 2022 | 29.58% | 20.49 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 28.68% | 22.92 | |
| 15 Sep 2022 | 28.77% | 16.08 | |
| 30 Sep 2022 | 26.86% | 15.15 | |
| 14 Oct 2022 | 25.85% | 26.64 | |
| 31 Oct 2022 | 25.29% | 23.84 | |
| 15 Nov 2022 | 22.90% | 15.27 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 21.60% | 20.56 | |
| 15 Dec 2022 | 20.39% | 17.44 | |
| 30 Dec 2022 | 20.78% | 15.93 |
See also: PMV Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.